Myriad Genetics reported $800K in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Accelerate Diagnostics AXDX:US 69K 1000
Agilent A:US $ 3M 0M
Becton, Dickinson and BDX:US $ 365M 0M
Bio Rad Laboratories BIO:US $ 0M 0M
Biocept BIOC:US $ 0M 0M
Bruker BRKR:US $ 1.7M 0M
Danaher DHR:US $ 9M 0M
Exact Sciences EXAS:US $ 1.76M 0.02M
Fluidigm FLDM:US $ 0.08M 0M
Hologic HOLX:US $ 3M 0M
Illumina ILMN:US $ 2M 0M
Johnson & Johnson JNJ:US $ 3120M 0M
Mettler Toledo International MTD:US 448K 0
Myriad Genetics MYGN:US $ 0.8M 0M
Nanostring Technologies NSTG:US $ 0M 0M
Orasure Technologies OSUR:US $ 0M 0M
Pacific Biosciences Of California PACB:US $ 0.22M 0M
Perkinelmer PKI:US $ 126.14M 0.1M
Quest Diagnostics DGX:US $ 2M 0M
Quidel QDEL:US $ 0.04M 0M
Repligen RGEN:US $ 0.55M 0M
Thermo Fisher Scientific TMO:US $ 440M 1M
Veracyte VCYT:US $ 0.07M 0M
Waters WAT:US $ 1.62M 0M